Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Graphical abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., et al. (2020) · Science · doi:10.1126/science.abb7498 · Cited by 1,609
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,478
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Tahir ul Qamar, M., Alqahtani, S. M., Alamri, M. A., & Chen, L.-L. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.009 · Cited by 1,032
Ma, C., Sacco, M. D., Hurst, B., Townsend, J. A., Hu, Y., Szeto, T., Zhang, X., Tarbet, B., Marty, M. T., Chen, Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0356-z · Cited by 880
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Mechanisms and enzymes involved in SARS coronavirus genome expression
Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.19424-0 · Cited by 848
Genomic characterization of a novel SARS-CoV-2
Khailany, R. A., Safdar, M., & Ozaslan, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100682 · Cited by 847
The SARS-CoV-2 main protease as drug target
Ullrich, S., & Nitsche, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127377 · Cited by 772
Emerging principles in protease-based drug discovery
Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601
Zhang, L., Lin, D., Kusov, Y., Nian, Y., Ma, Q., Wang, J., von Brunn, A., Leyssen, P., Lanko, K., Neyts, J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01828 · Cited by 568
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Yuen, C.-K., Lam, J.-Y., Wong, W.-M., Mak, L.-F., Wang, X., Chu, H., Cai, J.-P., Jin, D.-Y., To, K. K.-W., Chan, J. F.-W., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1780953 · Cited by 524
Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020) · Molecular Informatics · doi:10.1002/minf.202000028 · Cited by 517
Wang, J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00179 · Cited by 498
Zhang, D.-H., Wu, K.-L., Zhang, X., Deng, S.-Q., & Peng, B. (2020) · Journal of Integrative Medicine · doi:10.1016/j.joim.2020.02.005 · Cited by 482
Rut, W., Lv, Z., Zmudzinski, M., Patchett, S., Nayak, D., Snipas, S. J., El Oualid, F., Huang, T. T., Bekes, M., Drag, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd4596 · Cited by 459
COVID-19: Drug Targets and Potential Treatments
Gil, C., Ginex, T., Maestro, I., Nozal, V., Barrado-Gil, L., Cuesta-Geijo, M. Á., Urquiza, J., Ramírez, D., Alonso, C., Campillo, N. E., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00606 · Cited by 445
Chen, Y. W., Yiu, C.-P. B., & Wong, K.-Y. (2020) · F1000Research · doi:10.12688/f1000research.22457.2 · Cited by 426
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Kandeel, M., & Al-Nazawi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117627 · Cited by 412
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
Shah, B., Modi, P., & Sagar, S. R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117652 · Cited by 401
Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1760136 · Cited by 384
Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763201 · Cited by 380
Recent discovery and development of inhibitors targeting coronaviruses
Pillaiyar, T., Meenakshisundaram, S., & Manickam, M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.01.015 · Cited by 361
Bi-directional differentiation of single bronchioalveolar stem cells during lung repair
Liu, K., Tang, M., Liu, Q., Han, X., Jin, H., Zhu, H., Li, Y., He, L., Ji, H., & Zhou, B. (2020) · Cell Discovery · doi:10.1038/s41421-019-0132-8 · Cited by 360
Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1758791 · Cited by 350
Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1766572 · Cited by 347
Goyal, B., & Goyal, D. (2020) · ACS Combinatorial Science · doi:10.1021/acscombsci.0c00058 · Cited by 344
Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1761883 · Cited by 338
Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1751298 · Cited by 337
Chen, Y. W., Yiu, C.-P. B., & Wong, K.-Y. (2020) · F1000Research · doi:10.12688/f1000research.22457.1 · Cited by 323
Roles of flavonoids against coronavirus infection
Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109211 · Cited by 323
Peptide-like and small-molecule inhibitors against Covid-19
Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1757510 · Cited by 310
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
Hall, D. C., & Ji, H.-F. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101646 · Cited by 296
Freitas, B. T., Durie, I. A., Murray, J., Longo, J. E., Miller, H. C., Crich, D., Hogan, R. J., Tripp, R. A., & Pegan, S. D. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00168 · Cited by 290
Yu, R., Chen, L., Lan, R., Shen, R., & Li, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106012 · Cited by 290
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Reiner, Ž., Hatamipour, M., Banach, M., Pirro, M., Al-Rasadi, K., Jamialahmadi, T., Radenkovic, D., Montecucco, F., & Sahebkar, A. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.94655 · Cited by 263
Peele, K. A., Potla Durthi, C., Srihansa, T., Krupanidhi, S., Ayyagari, V. S., Babu, D. J., Indira, M., Reddy, A. R., & Venkateswarulu, T. C. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100345 · Cited by 228
Joshi, T., Joshi, T., Sharma, P., Mathpal, S., Pundir, H., Bhatt, V. D., & Chandra, S. (2020) · PubMed · doi:10.26355/eurrev_202004_21036 · Cited by 209
Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1768151 · Cited by 207
Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764868 · Cited by 199
Macchiagodena, M., Pagliai, M., & Procacci, P. (2020) · Chemical Physics Letters · doi:10.1016/j.cplett.2020.137489 · Cited by 172
Shamsi, A., Mohammad, T., Anwar, S., AlAjmi, M. F., Hussain, A., Rehman, M. T., Islam, A., & Hassan, M. I. (2020) · Bioscience Reports · doi:10.1042/bsr20201256 · Cited by 167
Gimeno, A., Mestres-Truyol, J., Ojeda-Montes, M. J., Macip, G., Saldivar-Espinoza, B., Cereto-Massagué, A., Pujadas, G., & Garcia-Vallvé, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113793 · Cited by 165
Fischer, A., Sellner, M., Neranjan, S., Smieško, M., & Lill, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103626 · Cited by 165
Computational Determination of Potential Inhibitors of SARS-CoV‑2 Main Protease
Ngô, S. T., Pham, N. Q. A., Le, L., Pham, D.-H., & Vu, V. V. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00491 · Cited by 163
Gurung, A. B., Ali, M. A., Lee, J., Farah, M. A., & Al‐Anazi, K. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117831 · Cited by 157
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
Huang, F., Li, Y., Leung, E. L., Liu, X., Liu, K., Qu, W., Lan, Y., Li, X., Yu, H., Cui, L., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104929 · Cited by 155
Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
Al-Khafaji, K., AL-Duhaidahawi, D., & Taşkın‐Tok, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764392 · Cited by 153
Su, H., Yao, S., Zhao, W., Li, M., Liu, J., Shang, W., Xie, H., Ke, C., Gao, M.-N., Yu, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.13.038687 · Cited by 143
Design of Aminopeptidase N Inhibitors as Anti-cancer Agents
Amin, S. A., Adhikari, N., & Jha, T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00782 · Cited by 133
Self-citationMolecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
Calligari, P. A., Bobone, S., Ricci, G., & Bocedi, A. (2020) · Viruses · doi:10.3390/v12040445 · Cited by 130
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Li, Q., & Kang, C. (2020) · Microorganisms · doi:10.3390/microorganisms8081250 · Cited by 127
Ren, X., Shao, X.-X., Li, X., Jia, X., Song, T., Zhou, W., Wang, P., Li, Y., Wang, X., Cui, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112932 · Cited by 126
Amin, S. A., Ghosh, K., Gayen, S., & Jha, T. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1780946 · Cited by 120
Self-citationWang, R., Hozumi, Y., Yin, C., & Wei, G. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00501 · Cited by 111
Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1752310 · Cited by 110
Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz‐Sánchez, Á. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1764393 · Cited by 106
Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock
Mothay, D., & Ramesh, K. V. (2020) · VirusDisease · doi:10.1007/s13337-020-00585-z · Cited by 105
Repositioning of 8565 Existing Drugs for COVID-19
Gao, K., Nguyen, D. D., Chen, J., Wang, R., & Wei, G. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c01579 · Cited by 104
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
Jiménez-Alberto, A., Ribas‐Aparicio, R. M., Aparicio‐Ozores, G., & Castelán-Vega, J. A. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107325 · Cited by 90
Fight against novel coronavirus: A perspective of medicinal chemists
Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112559 · Cited by 85
Self-citationKumar, V., & Roy, K. (2020) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2020.1776388 · Cited by 74
Tsuji, M. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12875 · Cited by 74
Ghosh, K., Amin, S. A., Gayen, S., & Jha, T. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129026 · Cited by 71
Self-citationLiang, J. J., Pitsillou, E., Karagiannis, C., Darmawan, K. K., Ng, K., Hung, A., & Karagiannis, T. C. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107292 · Cited by 68
Zhang, Z.-J., Wu, W., Hou, J., Zhang, L., Li, F., Gao, L., Wu, X., Shi, J.-Y., Zhang, R., Long, H., et al. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.03.004 · Cited by 60
Petushkova, A. I., & Zamyatnin, A. A. (2020) · Pharmaceuticals · doi:10.3390/ph13100277 · Cited by 54
Choudhury, C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1771424 · Cited by 51
Havranek, B., & Islam, S. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1776158 · Cited by 48
Abu‐Saleh, A. A. A., Awad, I. E., Yadav, A., & Poirier, R. A. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp04326e · Cited by 32
Cited by
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Mengist, H. M., Dilnessa, T., & Jin, T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.622898 · Cited by 302
Structural biology of SARS-CoV-2: open the door for novel therapies
Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 291
Metadata
- Authors
- Amin, S. A., Banerjee, S., Ghosh, K., Gayen, S., & Jha, T.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 29
- Pages
- 115860
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W3094827588
- Cited by
- 187
- References
- 85
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.